Neurobiology of Aging
Volume 26, Issue 7 , Pages 1005-1010 , July 2005

The association between promoter polymorphism of the interleukin-10 gene and Alzheimer's disease

  • Suk Ling Ma

      Affiliations

    • Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
    • Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
    • ,
  • Nelson Leung Sang Tang

      Affiliations

    • Department of Chemical Pathology, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
    • ,
  • Linda Chiu Wa Lam

      Affiliations

    • Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
    • Corresponding Author InformationCorresponding author. Tel.: +852 26076040; fax: +852 26671255.
    • ,
  • Helen Fung Kum Chiu

      Affiliations

    • Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China
    • Jockey Club Centre for Positive Ageing, Hong Kong, China

Received 29 October 2003 ,Revised 11 August 2004 ,Accepted 31 August 2004.

References 

  1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, et al. Inflammation and Alzheimer's disease. Neurobiol Aging. 2000;21:383–421
  2. Chan AS, Choi MK, Salmon DP. The effects of age, education, and gender on the Mattis Dementia Rating Scale performance of elderly Chinese and American individuals. J Gerontol B Psychol Sci Soc Sci. 2001;56:356–363
  3. Chiavetto LB, Boin F, Zanardini R, Popoli M, Michelato A, Bignotti S, et al. Association between promoter polymorphic haplotypes of interleukin-10 gene and schizophrenia. Biol Psychiatry. 2002;51:480–484
  4. Chiu HFK, Lee HC, Chung WS, Kwong PK. Reliability and validity of the Cantonese version of the Mini-Mental State Examination—a preliminary study. J Hong Kong Coll Psychiatrists. 1994;4:25–28
  5. De Luigi A, Fragiacomo C, Lucca U, Quadri P, Tettamanti M, Grazia De Simoni M. Inflammatory markers in Alzheimer's disease and multi-infarct dementia. Mech Ageing Dev. 2001;122:1985–1995
  6. Depboylu C, Du Y, Muller U, Kurz A, Zimmer R, Riemenschneider M, et al. Lack of association of interleukin-10 promoter region polymorphisms with Alzheimer's disease. Neurosci Lett. 2003;342:132–134
  7. Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmuller F, et al. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology. 2000;55:480–483
  8. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendrop RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci USA. 1998;95:9465–9470
  9. Hensler T, Sauerland S, Riess P, Hess S, Helling HJ, Andermahr J, et al. The effect of additional brain injury on systemic interleukin (IL)-10 and IL-13 levels in trauma patients. Inflamm Res. 2000;49:524–528
  10. Lang R, Rutschman RL, Greaves DR, Murray PJ. Autocrine deactivation of macrophages in transgenic mice constitutively overexpressing IL-10 under control of the human CD68 promoter. J Immunol. 2002;168:3402–3411
  11. Lei SF, Deng FY, Liu XH, Huang QR, Qin Y, Zhou Q, et al. Polymorphisms of four bone mineral density candidate genes in Chinese populations and comparison with other populations of different ethnicity. J Bone Miner Metab. 2003;21:34–42
  12. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, et al. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun. 2003;4:234–238
  13. Ma SL, Tang NL, Lam LC, Chiu HF. Lack of association of the interleukin-1beta gene polymorphism with Alzheimer's disease in a Chinese population. Dement Geriatr Cogn Disord. 2003;16:265–268
  14. Ma SL, Tang NL, Lam LC, Chiu HF. Association between tumor necrosis factor-alpha promoter polymorphism and Alzheimer's disease. Neurology. 2004;62:307–309
  15. Mak YT, Chiu H, Woo J, Kay R, Chan YS, Hui E, et al. E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology. 1996;46:146–149
  16. McCusker SM, Curran MD, Dynan KB, McCullagh CD, Urquhart DD, Middleton D, et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet. 2001;357:436–439
  17. McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer's disease. Exp Gerontol. 1998;33:371–378
  18. McGeer PL, McGeer EG. Polymorphisms in inflammatory genes and the risk of Alzheimer's disease. Arch Neurol. 2001;58:1790–1792
  19. Mok CC, Lanchbury JS, Chan DW, Lau CS. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998;41:1090–1095
  20. Mrak RE, Griffin WS. Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging. 2001;22:903–908
  21. Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol. 2000;47:365–368
  22. Remarque EJ, Bollen EL, Weverling-Rijnsburger AW, Laterveer JC, Blauw GJ, Westendorp RG. Patients with Alzheimer's disease display a pro-inflammatory phenotype. Exp Gerontol. 2001;36:171–176
  23. Roh JW, Kim MH, Seo SS, Kim SH, Kim JW, Park NH, et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett. 2002;184:57–63
  24. Scassellati C, Zanardini R, Squitti R, Bocchio-Chiavetto L, Bonvicini C, Binetti G, et al. Promoter haplotypes of interleukin-10 gene and sporadic Alzheimer's disease. Neurosci Lett. 2004;356:119–122
  25. Sheng JG, Mrak RE, Griffin WS. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol (Berl). 1998;95:229–234
  26. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, et al. Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype-phenotype association study in Japanese cases. Am J Med Genet. 2002;114:436–439
  27. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, et al. Interleukin-10 in the brain. Crit Rev Immunol. 2001;21:427–449
  28. Szczepanik AM, Ringheim GE. IL-10 and glucocorticoids inhibit Abeta(1–42)- and lipopolysaccharide-induced pro-inflammatory cytokine and chemokine induction in the central nervous system. J Alzheimers Dis. 2003;5:105–117
  29. Terwilliger JOJ. Handbook for human genetic linkage. Baltimore: John Hopkins University Press; 1994;
  30. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, et al. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med. 1993;121:598–602
  31. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8

PII: S0197-4580(04)00299-4

doi: 10.1016/j.neurobiolaging.2004.08.010

Neurobiology of Aging
Volume 26, Issue 7 , Pages 1005-1010 , July 2005

Article Tools

* Image Usage & Resolution